Clinical verification of (18)F-DCFPyL PET-detected lesions in patients with biochemically recurrent prostate cancer

PURPOSE: Radiolabeled Prostate-Specific Membrane Antigen (PSMA) PET/CT is the current standard-of-care for lesion detection in patients with biochemically recurrent (BCR) prostate cancer (PCa). However, rigorous verification of detected lesions is not always performed in routine clinical practice. T...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:PLoS One
Auteurs principaux: Meijer, Dennie, Jansen, Bernard H. E., Wondergem, Maurits, Bodar, Yves J. L., Srbljin, Sandra, Vellekoop, Annelies E., Keizer, Bram, van der Zant, Friso M., Hoekstra, Otto S., Nieuwenhuijzen, Jakko A., Dahele, Max, Vis, André N., Oprea-Lager, Daniela E.
Format: Artigo
Langue:Inglês
Publié: Public Library of Science 2020
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7537873/
https://ncbi.nlm.nih.gov/pubmed/33021980
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0239414
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires